🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tthe primary objective of this study is to compare blinded Independent Radi...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-04-24
Trial ID
NCT03428217
Treatments Being Tested
This study is designed to evaluate the effects of telaglenastat on cardiac ...
Status
Completed
Location
Celerion
Start Date
2020-10-05
Trial ID
NCT04607512
Treatments Being Tested
This phase Ib trial studies the side effects and best dose of telaglenastat...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-03-16
Trial ID
NCT03831932
This study is designed to formally evaluate the impact of famotidine, an H2...
Status
Completed
Location
Nucleus Network Brisbane Clinic (formerly Q-Pharm)
Start Date
2020-09-22
Trial ID
NCT04540965
Treatments Being Tested
This is a Phase 2, randomized, multicenter, double-blind study of the gluta...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2020-07-24
Trial ID
NCT04265534
The research study is being conducted to evaluate the effectiveness of a dr...
Status
Not Yet Recruiting
Location
UPMC Presybeterian
Start Date
2026-08
Trial ID
NCT07223528
Treatments Being Tested
This phase I trial studies the best dose of CB-839 HCl when given together ...
Status
Active Not Recruiting
Location
Yale University
Start Date
2019-07-08
Trial ID
NCT03798678
Treatments Being Tested
This phase I/Ib trial studies the side effects and best dose of CB-839 HCl ...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2020-10-26
Trial ID
NCT04250545
Treatments Being Tested
The primary objective of this study is to compare the progression-free surv...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2017-09-06
Trial ID
NCT03163667
Treatments Being Tested
CX-839-007 is an open-label Phase 2 study of the combination of CB-839 with...
Status
Completed
Location
University of Alabama at Brimingham
Start Date
2017-05-01
Trial ID
NCT03057600
Treatments Being Tested